MedTrace Logo

Compliant Analysis of Patient Samples and Data

NCT04364503 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2024-10-16

No results posted yet for this study

Summary

Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. Other commercial patients will be followed up on after informed consent is obtained.

Conditions

Interventions

DEVICE

Multiple interventions depending on diagnostic test being run.

Remnant samples and corresponding data from multiple diagnostic tests will be stored for future research and development.

Sponsors & Collaborators

  • Laboratory Corporation of America

    collaborator INDUSTRY

  • Sequenom, Inc.

    lead INDUSTRY

Principal Investigators

  • Graham P McLennan · Sequenom, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-17
Primary Completion
2030-03-17
Completion
2030-08-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04364503 on ClinicalTrials.gov